IL17A and fibrosis: MSG acts by modifying the key cytokines and growth factors that include the effects of TGF-β, IL-17, IL-19, and VEGF on inflammation, the deposition of collagen, and angiogenesis, which lead to the characteristic tissue remodeling seen in fibrosis.